Downstream Processing of Transgenic Plant Systems: Protein Recovery and Purification Strategies

作者: Lisa R. Wilken , Zivko L. Nikolov

DOI: 10.1007/978-94-007-2217-0_11

关键词:

摘要: Plant-derived recombinant proteins provide alternatives to produced by mammalian, microbial, and insect cell cultures due significant upstream technological achievements over the past 5–10 years. Plants offer flexibility in both growth methods (open-field, greenhouse, bioreactor) host expression systems (seeds, leaves, culture). The diversity of plant production provides for numerous commercial applications plant-derived but economic viability must be ensured through high levels scalable manufacturing processes. Initial research efforts biotechnology were focused on strategies and, thus, have not matched downstream processing advancements. However, case-by-case extraction studies led development system-based approaches. Other progress includes pretreatment improve purification efficiency reduce costs from green tissue homogenates that contain chlorophyll, phenolics, active enzymes. In spite all positive developments made last 10 years, continual breakthroughs are needed capitalize lower cost transgenic biomass. This chapter describes general advantages disadvantages seed-, leaf-, bioreactor-based used primary recovery proteins.

参考文章(146)
Zivko L. Nikolov, Jeffrey T. Regan, Lynn F. Dickey, Susan L. Woodard, Purification of Antibodies From Transgenic Plants John Wiley & Sons, Inc.. pp. 387- 406 ,(2008) , 10.1002/9780470444894.CH19
Gregory P. Pogue, Fakhrieh Vojdani, Kenneth E. Palmer, Ernie Hiatt, Steve Hume, Jim Phelps, Lori Long, Natasha Bohorova, Do Kim, Michael Pauly, Jesus Velasco, Kevin Whaley, Larry Zeitlin, Stephen J. Garger, Earl White, Yun Bai, Hugh Haydon, Barry Bratcher, Production of pharmaceutical‐grade recombinant aprotinin and a monoclonal antibody product using plant‐based transient expression systems Plant Biotechnology Journal. ,vol. 8, pp. 638- 654 ,(2010) , 10.1111/J.1467-7652.2009.00495.X
Joseph Boothe, Yin Shen, Keon Richard Glenn, Gijs van Rooijen, Commercial production of chymosin in plants ,(2000)
John A. Howard, Zivko Nikolov, Elizabeth E. Hood, Enzyme Production Systems for Biomass Conversion Plant Biomass Conversion. pp. 227- 253 ,(2011) , 10.1002/9780470959138.CH10
Rainer Fischer, Eva Stöger, Carmen Vaquero, Esperanza Torres, Markus Sack, Liz Nicholson, Jürgen Drossard, Sarah Williams, Duncan Keen, Yolande Perrin, Paul Christou, Cereal crops as viable production and storage systems for pharmaceutical scFv antibodies. Plant Molecular Biology. ,vol. 42, pp. 583- 590 ,(2000) , 10.1023/A:1006301519427
Marc-André D'Aoust, Patrice Lerouge, Ursula Busse, Pierre Bilodeau, Sonia Trépanier, Véronique Gomord, Loïc Faye, Louis-Philippe Vézina, Efficient and Reliable Production of Pharmaceuticals in Alfalfa Wiley‐VCH Verlag GmbH & Co. KGaA. pp. 1- 12 ,(2005) , 10.1002/3527603638.CH1
Glynis Giddings, Gordon Allison, Douglas Brooks, Adrian Carter, Transgenic plants as factories for biopharmaceuticals Nature Biotechnology. ,vol. 18, pp. 1151- 1155 ,(2000) , 10.1038/81132
Larry Zeitlin, Stuart S. Olmsted, Thomas R. Moench, Man Sung Co, Brian J. Martinell, Vikram M. Paradkar, David R. Russell, Cary Queen, Richard A. Cone, Kevin J. Whaley, A humanized monoclonal antibody produced in transgenic plants for immunoprotection of the vagina against genital herpes Nature Biotechnology. ,vol. 16, pp. 1361- 1364 ,(1998) , 10.1038/4344